Publication Type Review
Authors Spano M, Roytman M, Aboian M, Saboury B, Franceschi A, Chiang G
Journal PET Clin
Volume 18
Issue 1
Pagination 103-113
Date Published 01/01/2023
ISSN 1879-9809
Keywords Cognitive Dysfunction, Alzheimer Disease
Abstract Alzheimer disease (AD) is the most common cause of dementia, accounting for 50% to 60% of cases and affecting nearly 6 million people in the United States. Definitive diagnosis requires either antemortem brain biopsy or postmortem autopsy. However, clinical neuroimaging has been playing a greater role in the diagnosis and management of AD, and several PET tracers approach the sensitivity of tissue diagnosis in identifying AD pathologic condition. This review will focus on the utility of PET imaging in the setting of cognitive impairment, with an emphasis on its role in the diagnosis of AD.
DOI 10.1016/j.cpet.2022.09.006
PubMed ID 36442959
PubMed Central ID PMC9713600
Back to Top